- Home
- LOAN vs TLPH Comparison
LOAN vs TLPH Comparison
Compare LOAN & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LOAN | TLPH |
|---|---|---|
| Founded | 1989 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.2M | 42.3M |
| IPO Year | 1999 | 2010 |
Fundamental Metrics
Financial Performance| Metric | LOAN | TLPH |
|---|---|---|
| Price | $4.43 | $1.05 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 17.2K | ★ 242.5K |
| Earning Date | 04-16-2026 | 05-13-2026 |
| Dividend Yield | ★ 10.06% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $8,666,307.00 | $2,151,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $40.45 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.13 | $0.38 |
| 52 Week High | $5.85 | $1.57 |
Technical Indicators
Market Signals| Indicator | LOAN | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 61.14 | 63.00 |
| Support Level | $4.41 | $1.01 |
| Resistance Level | $4.48 | $1.44 |
| Average True Range (ATR) | 0.08 | 0.08 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 86.96 | 74.85 |
Price Performance
Historical ComparisonAbout LOAN Manhattan Bridge Capital Inc
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.